[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review

August 2021 | 56 pages | ID: CBD9BF3C95CBEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cryoport Inc (Cryoport) is a provider of cold chain logistics solutions. The company manages its shipments through Cryoportal, a cloud-based logistics management platform. It provides logistics consulting for supply chain including carrier validation, packaging, and accessory design, lane validation, lane assessment, fleet management, laboratory relocation services, commercial launch designing, clinical research expertise, and training services. It offers services to therapy developers for personalized medicine, contract research organizations, cord blood repositories, vaccine manufacturers, bio-pharmaceutical institutions, contract manufacturers, diagnostic laboratories, clinical trial centers, academic and research institutions, in-vitro fertility (IVF) industry and animal husbandry related companies. The company has operations in the Americas, Europe, the Middle East and Africa (EMEA) and Asia-Pacific. Cryoport is headquartered in Brentwood, Tennessee, the US.

CryoPort Inc Key Recent Developments

Aug 05,2021: Cryoport Reports Record Second Quarter 2021 Revenue
May 04,2021: Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021
Mar 03,2021: Cryoport Announces Appointment of Linda Baddour to its Board of Directors
Mar 01,2021: Cryoport Reports Record Results for Full Year 2020
Feb 25,2021: Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

CryoPort Inc - Key Facts
CryoPort Inc - Key Employees
CryoPort Inc - Key Employee Biographies
CryoPort Inc - Major Products and Services
CryoPort Inc - History
CryoPort Inc - Company Statement
CryoPort Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
CryoPort Inc - Business Description
Other Break-up: Animal Health
Overview
Performance
Other Break-up: Biopharma/Pharma
Overview
Performance
Other Break-up: Human Reproductive Medicine
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, the Middle East and Africa
Performance
R&D Overview
CryoPort Inc - SWOT Analysis
SWOT Analysis - Overview
CryoPort Inc - Strengths
CryoPort Inc - Weaknesses
CryoPort Inc - Opportunities
CryoPort Inc - Threats
CryoPort Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
CryoPort Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 05, 2021: Cryoport Reports Record Second Quarter 2021 Revenue
May 04, 2021: Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021
Mar 03, 2021: Cryoport Announces Appointment of Linda Baddour to its Board of Directors
Mar 01, 2021: Cryoport Reports Record Results for Full Year 2020
Feb 25, 2021: Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021
Dec 08, 2020: Cryoport and CCRM Fertility enter into agreement
Nov 05, 2020: Cryoport reports 2020 third-quarter results
Oct 29, 2020: Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020
Aug 06, 2020: Cryoport reports 2020 second-quarter results
Aug 04, 2020: MEDIPAL partners with CRYOPORT to bring temperature-controlled supply chain solutions to the Japanese market

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

CryoPort Inc, Key Facts
CryoPort Inc, Key Employees
CryoPort Inc, Key Employee Biographies
CryoPort Inc, Major Products and Services
CryoPort Inc, History
CryoPort Inc, Other Locations
CryoPort Inc, Subsidiaries
CryoPort Inc, Key Competitors
CryoPort Inc, Ratios based on current share price
CryoPort Inc, Annual Ratios
CryoPort Inc, Annual Ratios (Cont...1)
CryoPort Inc, Interim Ratios
CryoPort Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

CryoPort Inc, Performance Chart (2016 - 2020)
CryoPort Inc, Ratio Charts


More Publications